Opioid Use Disorder Research Study
Johns Hopkins University is conducting a study to evaluate the impact of an FDA-approved medication for sleep on the effects of commonly used drugs.
Fast Facts
Ages 18-65
Currently use Opioids Recreationally
Compensation Provided
Conducted in Baltimore, MD
Study Background
Researchers at Johns Hopkins University are seeking to understand the FDA-approved sleep medication suvorexant on the effects of commonly use drugs.
During this study, you will complete an eligibility screening at Bayview Medical Center in Baltimore, Maryland. If you eligible based on that screening, you will admit yourself to our inpatient research unit for a 14-16 day period.
During the study, we will maintain you on the opioid drug hydromorphone throughout your stay to help prevent opioid withdrawal. You will also complete five study sessions where the effect of commonly used drugs on behavior and mood is evaluated.
Join our compensated study!
Study Background
Researchers at Johns Hopkins University are seeking to understand the FDA-approved sleep medication suvorexant on the effects of commonly use drugs.
During this study, you will complete an eligibility screening at Bayview Medical Center in Baltimore, Maryland. If you eligible based on that screening, you will admit yourself to our inpatient research unit for a 14-16 day period.
During the study, we will maintain you on the opioid drug hydromorphone throughout your stay to help prevent opioid withdrawal. You will also complete five study sessions where the effect of commonly used drugs on behavior and mood is evaluated.
Join our compensated study!
Additional Information
To evaluate the impact of an FDA-approved medication for sleep on the effects of commonly used drugs.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
- Age 18 to 65 years old
- Not seeking treatment for substance use
- Current non-medical/recreational opioid use
- Current opioid use disorder
Once enrolled in this study, participants can expect:
- One Screening visit that lasts 3-4 hours (in person)
- One 14-16 day residential stay where you will be asked to stay in a hospital room at Bayview Medical Center (in person)
Compensation is provided up to $2730 for your participation.
- Screening ($30)
- Residential Stay ($75/day + $75/day if completor)
- Demand Task (up to $300)
There is no cost for you to participate in this study. Transportation options available for the inpatient stay.
